Device for whole blood separation

US11650200B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11650200-B2
Application numberUS-202017138466-A
CountryUS
Kind codeB2
Filing dateDec 30, 2020
Priority dateNov 16, 2016
Publication dateMay 16, 2023
Grant dateMay 16, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Separation of the cellular components of whole blood, or other biological fluid, from plasma or serum can be achieved for assay analysis. A device for facilitating separation can include, for example, a capillary tube that accurately draws target blood volume, a pad that chemically interacts with red-blood cells, such that the red blood cells become chemically and/or physically trapped within pad material, a mechanism for plasma recovery from the pad upon diffusion or active mixing, and a dropper tip that facilitates dispensing the mixture onto a test device. The treatment of the cellular components can be performed prior to contact with a buffer solution, so release of the cellular components into the buffer solution is reduced or prevented. Additional filtration can be provided to filter any remaining cellular components in the mixture.

First claim

Opening claim text (preview).

What is claimed is: 1. A device comprising: an inflow chamber for receiving a fluid sample; a mixing chamber; a pad between the inflow chamber and the mixing chamber, the pad comprising a processing reagent; an outflow port adjacent to the mixing chamber; and an interface for sealably connecting the device to a container; wherein the container comprises a reservoir and the interface for sealably connecting the device to the container is configured such that the reservoir is in fluid communication with the mixing chamber through a channel formed between the interface and the pad, wherein the channel provides a pathway for reagents from the container to the mixing chamber. 2. The device of claim 1 , wherein the inflow chamber comprises a capillary tube. 3. The device of claim 2 , wherein the capillary tube has a length selected to collect a fixed volume of fluid sample. 4. The device of claim 1 , wherein the sample device further comprises a filter between the mixing chamber and the outflow port. 5. The device of claim 1 , further comprising a buffer solution within the reservoir. 6. The device of claim 1 , wherein the processing reagent is a red blood cell agglomerating substance. 7. A kit comprising: the device of claim 1 and a collection device. 8. The kit of claim 7 , further comprising the container. 9. A device comprising: an inflow chamber comprising a pad for receiving a liquid sample; and a mixing chamber having an outflow port; wherein the device is configured to sealably connect to a container, said container comprising: a reservoir configured to contain or containing reagents; and an interface for sealably connecting the device to the container such that the reservoir is in fluid communication with the mixing chamber through a channel formed between the interface and the pad, wherein the channel provides a pathway for the reagents from the container to the mixing chamber. 10. The device of claim 9 , further comprising a collection device for collecting the liquid sample. 11. The device of claim 10 , wherein the collection device comprises a capillary tube and a bulb in fluid communication with the capillary tube. 12. The device of claim 9 , wherein the pad comprises a processing reagent. 13. The device of claim 12 , wherein the processing reagent is a red blood cell agglomerating substance. 14. A kit comprising: the device of claim 9 and a collection device. 15. The kit of claim 14 , further comprising the container.

Assignees

Inventors

Classifications

  • Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor · CPC title

  • Separation devices for use in medical, pharmaceutical or laboratory applications, e.g. separating amalgam from dental treatment residues · CPC title

  • by separating the blood components (G01N15/05 takes precedence) · CPC title

  • Control and use of surface tension forces, e.g. hydrophobic, hydrophilic · CPC title

  • Partitioning blood components · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11650200B2 cover?
Separation of the cellular components of whole blood, or other biological fluid, from plasma or serum can be achieved for assay analysis. A device for facilitating separation can include, for example, a capillary tube that accurately draws target blood volume, a pad that chemically interacts with red-blood cells, such that the red blood cells become chemically and/or physically trapped within p…
Who is the assignee on this patent?
Quidel Corp
What technology area does this patent fall under?
Primary CPC classification G01N33/5002. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).